CN103597098A - 病毒诊断 - Google Patents

病毒诊断 Download PDF

Info

Publication number
CN103597098A
CN103597098A CN201280012143.3A CN201280012143A CN103597098A CN 103597098 A CN103597098 A CN 103597098A CN 201280012143 A CN201280012143 A CN 201280012143A CN 103597098 A CN103597098 A CN 103597098A
Authority
CN
China
Prior art keywords
lcmv
seq
antibody
primer
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280012143.3A
Other languages
English (en)
Chinese (zh)
Inventor
J.托马斯科瓦
J.科帕塞克
J.帕斯托雷克
S.帕斯托雷科瓦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOSCIENCE SLOVAKIA
Original Assignee
BIOSCIENCE SLOVAKIA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOSCIENCE SLOVAKIA filed Critical BIOSCIENCE SLOVAKIA
Publication of CN103597098A publication Critical patent/CN103597098A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN201280012143.3A 2011-01-07 2012-01-06 病毒诊断 Pending CN103597098A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161430822P 2011-01-07 2011-01-07
US61/430,822 2011-01-07
PCT/IB2012/000293 WO2012093340A2 (en) 2011-01-07 2012-01-06 Viral diagnostics

Publications (1)

Publication Number Publication Date
CN103597098A true CN103597098A (zh) 2014-02-19

Family

ID=45878971

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280012143.3A Pending CN103597098A (zh) 2011-01-07 2012-01-06 病毒诊断

Country Status (7)

Country Link
US (1) US8883429B2 (enExample)
EP (2) EP2664680A1 (enExample)
JP (1) JP2014502848A (enExample)
CN (1) CN103597098A (enExample)
AU (1) AU2012204757A1 (enExample)
CA (1) CA2823876A1 (enExample)
WO (1) WO2012093340A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112996802A (zh) * 2018-09-12 2021-06-18 阿巴洛斯治疗有限公司 用于制备抗肿瘤沙粒病毒的方法以及沙粒病毒突变体
CN119080935A (zh) * 2024-10-11 2024-12-06 上海市同仁医院 一种抗人SMIM45-107aa单克隆抗体及其用途

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4186978A1 (en) 2007-12-27 2023-05-31 Universität Zürich Replication-defective arenavirus vectors
WO2011063127A1 (en) 2009-11-18 2011-05-26 University Of Medicine And Dentistry Of New Jersey Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
US9849192B2 (en) 2009-11-18 2017-12-26 Rutgers, The State University Of New Jersey Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
US9549993B2 (en) 2012-10-02 2017-01-24 Rutgers, The State University Of New Jersey Specific delivery of toxins conjugated with antibodies to activate matripase
EP2968506B1 (en) * 2013-03-15 2019-07-31 Université de Genève Anti-mycobacterial vaccines
HRP20211015T1 (hr) 2013-12-03 2021-10-01 Hookipa Biotech Gmbh Cjepivo protiv citomegalovirusa (cmv)
WO2015183895A1 (en) * 2014-05-27 2015-12-03 University Of Rochester Novel arenavirus vaccine
EP3429586A4 (en) 2016-03-18 2020-03-11 Rutgers, the State University of New Jersey TARGETING TUMOR CELLS WITH CHEMOTHERAPEUTIC AGENTS CONJUGATED TO ANTI-MATRIPTASE ANTIBODIES BY IN VIVO-CLAVABLE LINKAGES
KR102446014B1 (ko) * 2022-04-19 2022-09-23 주식회사 웰에이블 저시력자용 진단키트 전용 커버

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ADRIAN CIUREA 等: "Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice", 《PNAS》 *
DAVID G. BESSELSEN等: "Detection of Lymphocytic Choriomeningitis Virus by Use of Fluorogenic Nuclease Reverse Transcriptase-Polymerase Chain Reaction Analysis", 《COMPARATIVE MEDICINE》 *
DENISE J. JAMIESON等: "Lymphocytic choriomeningitis virus: An emerging obstetric pathogen?", 《AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY》 *
JANA TOMASKOVA等: "Molecular characterization of the genes coding for glycoprotein and L protein of lymphocytic choriomeningitis virus strain MX", 《VIRUS GENES》 *
MCCAUSLAND等: "Quantitative PCR (QPCR) technique for detecting lymphocytic choriomeningitis virus (LCMV) in vivo", 《VIROL METHODS》 *
SIMON VIETH等: "RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene", 《TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112996802A (zh) * 2018-09-12 2021-06-18 阿巴洛斯治疗有限公司 用于制备抗肿瘤沙粒病毒的方法以及沙粒病毒突变体
CN119080935A (zh) * 2024-10-11 2024-12-06 上海市同仁医院 一种抗人SMIM45-107aa单克隆抗体及其用途

Also Published As

Publication number Publication date
WO2012093340A3 (en) 2012-12-13
AU2012204757A1 (en) 2013-05-02
US8883429B2 (en) 2014-11-11
US20120237922A1 (en) 2012-09-20
CA2823876A1 (en) 2012-07-12
WO2012093340A2 (en) 2012-07-12
EP2661509A2 (en) 2013-11-13
JP2014502848A (ja) 2014-02-06
EP2664680A1 (en) 2013-11-20

Similar Documents

Publication Publication Date Title
CN103597098A (zh) 病毒诊断
KR101785290B1 (ko) 중증 열성 혈소판 감소 증후군 바이러스 감염 진단용 단클론항체, 이를 생산하는 하이브리도마 및 이 단클론항체를 사용하는 중증 열성 혈소판 감소 증후군 바이러스 감염 진단방법
CN105378099B (zh) Hcv核心脂质结合结构域单克隆抗体
CN110383068A (zh) 评估患者样品中uch-l1状态的改进方法
KR102227648B1 (ko) B형 인플루엔자 바이러스의 측정 방법
US12188053B2 (en) Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses
WO2023088443A1 (zh) 一种抗人IgM抗体及其制备方法和用途
WO2023088444A1 (zh) 一种抗hiv-1 p24的抗体及其制备方法和用途
JP2017505124A (ja) ヘンドラ及びニパウイルスのｆ糖タンパク質に対する抗体
WO2021209824A1 (en) Methods and products for serological analysis of sars-cov-2 infection
Broering et al. Identification of human monoclonal antibodies specific for human SOD1 recognizing distinct epitopes and forms of SOD1
CN104024275A (zh) 对于人β1-肾上腺素受体（β1-AR）的结合化合物以及它们在测量自身抗β1-AR抗体中的应用
CN102232087A (zh) 修饰的人igf-1/e肽的抗体
US20220380442A1 (en) Human monoclonal antibodies to hantavirus and methods of use therefore
US20250347699A1 (en) Sars-cov-2 polypeptide, anti-sars-cov-2 antibodies and uses thereof
ES2660372T3 (es) Sustancias y procedimientos para la utilización en la prevención y/o el tratamiento en la enfermedad de Huntington
Fayaz et al. Development and characterization of mouse monoclonal antibodies to canine morbillivirus
US20230054956A1 (en) Human monoclonal antibodies that neutralize pandemic gii.4 noroviruses
US20240069037A1 (en) Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
US20220043000A1 (en) Methods and kits for detecting sars-cov-2 protein in a sample
WO2018140242A1 (en) Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
US20240124562A1 (en) Monoclonal antibodies and uses thereof
US20190375834A1 (en) Disulfide-type hmgb1-specific antibody, method for measuring disulfide-type hmgb1 and kit for said measurement, and measurement method capable of quantitating all of hmgb1 molecules including reduced hmgb1, disulfide-type hmgb1 and thrombin-cleavable hmgb1 and kit for said measurement
EP1765867B1 (en) Monoclonal antibodies to hiv-1 vpr and methods of using same
CN112979791B (zh) 针对新型冠状病毒的抗体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140219